Services

There are many complex steps and requirements to achieving coverage on public, private, and hospital formularies.  Success requires an expertise in developing and integrating the right payer messaging and strategies at the right times in a product's life-cycle.

How we work ... What we do ... Our different approach ...

What sets us apart is our experience-based understanding of government, industry & patient challenges.  We effectively manage all aspects of Canadian market access, from early global strategic planning to the design of Phase 4 data collection programs to facilitate or improve coverage. We are experienced in a diversity of access issues across a broad spectrum of therapeutic areas, such as Oncology, Infectious Disease, Neurology, Dermatology, Gastrointestinal, Endocrinology, Respiratory, Bone, Cardiovascular, Biologics, Novel Delivery Systems, Rare Disease Therapies, and many other highly specialized products. We approach product coverage from the payer perspective, and work to provide our clients with consistent messaging and strategies.  We specialize in achieveing optimal coverage for new pharmaceuticals, including specialty pharmaceuticals, biologics, and genetically-based therapies.